Dream Structure in Parkinsonʼs Patients

Dream reports of patients with Parkinsonʼs disease (PD) were analyzed to ascertain whether cognitive deficits associated with this nonfocal brain pathology influence dream structure or dream recall. Fifteen outpatients with idiopathic PD were sampled (diagnosed from 1 to 10 years and currently in st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of nervous and mental disease 1992-08, Vol.180 (8), p.516-523
Hauptverfasser: CIPOLLI, CARLO, BOLZANI, ROBERTO, MASSETANI, ROBERTO, MURRI, LUIGI, MURATORIO, ALBERTO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 523
container_issue 8
container_start_page 516
container_title The journal of nervous and mental disease
container_volume 180
creator CIPOLLI, CARLO
BOLZANI, ROBERTO
MASSETANI, ROBERTO
MURRI, LUIGI
MURATORIO, ALBERTO
description Dream reports of patients with Parkinsonʼs disease (PD) were analyzed to ascertain whether cognitive deficits associated with this nonfocal brain pathology influence dream structure or dream recall. Fifteen outpatients with idiopathic PD were sampled (diagnosed from 1 to 10 years and currently in stage II or III of Hoehn and Yarhʼs scale); all were without psychiatric symptoms or major medical illnesses and were currently being treated with L-dopa. After an adaptation night in the sleep laboratory, each patient spent a night in which he/she was awakened at least twice in rapid eye movement sleep and asked to report dream experience. Thirteen patients were able to report at least one dream. Overall frequency of dream recall (71.4%) was fully compatible with normative data for the elderly. Multiple regression analyses showed that both the length of the dream report as story and the organization of contents into coherent episodes (analyzed using Mandler and Johnsonʼs story grammar) varied significantly in relation to level of cognitive functioning and, in part, of language comprehension, but not in relation to age, illness duration, and dose of L-dopa.
doi_str_mv 10.1097/00005053-199208000-00007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73133363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73133363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3847-82fba784ab7399a5313ab3dfe48f0b5818f4b2c9c331b573624442c3215991943</originalsourceid><addsrcrecordid>eNp1kc1KAzEQx4MotVYfQdiDiJfVJJM0yVHqJxQUVPAWsmmWrt2PmuxSfDefwKcydWs9OZdhZn7zwX8QSgg-J1iJCxyNYw4pUYpiGaN0nRI7aEg4qFTA-HUXDTGmNAVM5D46COENYyKA4QEaEI6xAjZEZ1femSp5an1n2867pKiTR-MXRR2a-uszxKAtXN2GQ7SXmzK4o40foZeb6-fJXTp9uL2fXE5TC5KJVNI8M0IykwlQynAgYDKY5Y7JHGdcEpmzjFplAUjG45mUMUYtUMKVIorBCJ32c5e-ee9caHVVBOvK0tSu6YIWcSLAGCIoe9D6JgTvcr30RWX8hyZYr0XSvyLprUg_KRFbjzc7uqxys7_GXpVYP9nUTbCmzL2pbRG2GGdqzAWJGOuxVVO2zodF2a2c13Nnynau_3sRfAO3uHxU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73133363</pqid></control><display><type>article</type><title>Dream Structure in Parkinsonʼs Patients</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>CIPOLLI, CARLO ; BOLZANI, ROBERTO ; MASSETANI, ROBERTO ; MURRI, LUIGI ; MURATORIO, ALBERTO</creator><creatorcontrib>CIPOLLI, CARLO ; BOLZANI, ROBERTO ; MASSETANI, ROBERTO ; MURRI, LUIGI ; MURATORIO, ALBERTO</creatorcontrib><description>Dream reports of patients with Parkinsonʼs disease (PD) were analyzed to ascertain whether cognitive deficits associated with this nonfocal brain pathology influence dream structure or dream recall. Fifteen outpatients with idiopathic PD were sampled (diagnosed from 1 to 10 years and currently in stage II or III of Hoehn and Yarhʼs scale); all were without psychiatric symptoms or major medical illnesses and were currently being treated with L-dopa. After an adaptation night in the sleep laboratory, each patient spent a night in which he/she was awakened at least twice in rapid eye movement sleep and asked to report dream experience. Thirteen patients were able to report at least one dream. Overall frequency of dream recall (71.4%) was fully compatible with normative data for the elderly. Multiple regression analyses showed that both the length of the dream report as story and the organization of contents into coherent episodes (analyzed using Mandler and Johnsonʼs story grammar) varied significantly in relation to level of cognitive functioning and, in part, of language comprehension, but not in relation to age, illness duration, and dose of L-dopa.</description><identifier>ISSN: 0022-3018</identifier><identifier>EISSN: 1539-736X</identifier><identifier>DOI: 10.1097/00005053-199208000-00007</identifier><identifier>PMID: 1500934</identifier><identifier>CODEN: JNMDAN</identifier><language>eng</language><publisher>Hagerstown, MD: Williams &amp; Wilkins</publisher><subject>Age Factors ; Aged ; Ambulatory Care ; Biological and medical sciences ; Cognition Disorders - diagnosis ; Cognition Disorders - psychology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dose-Response Relationship, Drug ; Dreams - drug effects ; Dreams - psychology ; Female ; Humans ; Language Tests ; Levodopa - pharmacology ; Levodopa - therapeutic use ; Male ; Medical sciences ; Mental Recall - drug effects ; Middle Aged ; Neurology ; Neuropsychological Tests ; Parkinson Disease - diagnosis ; Parkinson Disease - drug therapy ; Parkinson Disease - psychology ; Time Factors</subject><ispartof>The journal of nervous and mental disease, 1992-08, Vol.180 (8), p.516-523</ispartof><rights>Williams &amp; Wilkins 1992. All Rights Reserved.</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3847-82fba784ab7399a5313ab3dfe48f0b5818f4b2c9c331b573624442c3215991943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5496571$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1500934$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CIPOLLI, CARLO</creatorcontrib><creatorcontrib>BOLZANI, ROBERTO</creatorcontrib><creatorcontrib>MASSETANI, ROBERTO</creatorcontrib><creatorcontrib>MURRI, LUIGI</creatorcontrib><creatorcontrib>MURATORIO, ALBERTO</creatorcontrib><title>Dream Structure in Parkinsonʼs Patients</title><title>The journal of nervous and mental disease</title><addtitle>J Nerv Ment Dis</addtitle><description>Dream reports of patients with Parkinsonʼs disease (PD) were analyzed to ascertain whether cognitive deficits associated with this nonfocal brain pathology influence dream structure or dream recall. Fifteen outpatients with idiopathic PD were sampled (diagnosed from 1 to 10 years and currently in stage II or III of Hoehn and Yarhʼs scale); all were without psychiatric symptoms or major medical illnesses and were currently being treated with L-dopa. After an adaptation night in the sleep laboratory, each patient spent a night in which he/she was awakened at least twice in rapid eye movement sleep and asked to report dream experience. Thirteen patients were able to report at least one dream. Overall frequency of dream recall (71.4%) was fully compatible with normative data for the elderly. Multiple regression analyses showed that both the length of the dream report as story and the organization of contents into coherent episodes (analyzed using Mandler and Johnsonʼs story grammar) varied significantly in relation to level of cognitive functioning and, in part, of language comprehension, but not in relation to age, illness duration, and dose of L-dopa.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Ambulatory Care</subject><subject>Biological and medical sciences</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - psychology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dose-Response Relationship, Drug</subject><subject>Dreams - drug effects</subject><subject>Dreams - psychology</subject><subject>Female</subject><subject>Humans</subject><subject>Language Tests</subject><subject>Levodopa - pharmacology</subject><subject>Levodopa - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Recall - drug effects</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Parkinson Disease - diagnosis</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - psychology</subject><subject>Time Factors</subject><issn>0022-3018</issn><issn>1539-736X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1KAzEQx4MotVYfQdiDiJfVJJM0yVHqJxQUVPAWsmmWrt2PmuxSfDefwKcydWs9OZdhZn7zwX8QSgg-J1iJCxyNYw4pUYpiGaN0nRI7aEg4qFTA-HUXDTGmNAVM5D46COENYyKA4QEaEI6xAjZEZ1femSp5an1n2867pKiTR-MXRR2a-uszxKAtXN2GQ7SXmzK4o40foZeb6-fJXTp9uL2fXE5TC5KJVNI8M0IykwlQynAgYDKY5Y7JHGdcEpmzjFplAUjG45mUMUYtUMKVIorBCJ32c5e-ee9caHVVBOvK0tSu6YIWcSLAGCIoe9D6JgTvcr30RWX8hyZYr0XSvyLprUg_KRFbjzc7uqxys7_GXpVYP9nUTbCmzL2pbRG2GGdqzAWJGOuxVVO2zodF2a2c13Nnynau_3sRfAO3uHxU</recordid><startdate>199208</startdate><enddate>199208</enddate><creator>CIPOLLI, CARLO</creator><creator>BOLZANI, ROBERTO</creator><creator>MASSETANI, ROBERTO</creator><creator>MURRI, LUIGI</creator><creator>MURATORIO, ALBERTO</creator><general>Williams &amp; Wilkins</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199208</creationdate><title>Dream Structure in Parkinsonʼs Patients</title><author>CIPOLLI, CARLO ; BOLZANI, ROBERTO ; MASSETANI, ROBERTO ; MURRI, LUIGI ; MURATORIO, ALBERTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3847-82fba784ab7399a5313ab3dfe48f0b5818f4b2c9c331b573624442c3215991943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Ambulatory Care</topic><topic>Biological and medical sciences</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - psychology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dose-Response Relationship, Drug</topic><topic>Dreams - drug effects</topic><topic>Dreams - psychology</topic><topic>Female</topic><topic>Humans</topic><topic>Language Tests</topic><topic>Levodopa - pharmacology</topic><topic>Levodopa - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Recall - drug effects</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Parkinson Disease - diagnosis</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - psychology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CIPOLLI, CARLO</creatorcontrib><creatorcontrib>BOLZANI, ROBERTO</creatorcontrib><creatorcontrib>MASSETANI, ROBERTO</creatorcontrib><creatorcontrib>MURRI, LUIGI</creatorcontrib><creatorcontrib>MURATORIO, ALBERTO</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of nervous and mental disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CIPOLLI, CARLO</au><au>BOLZANI, ROBERTO</au><au>MASSETANI, ROBERTO</au><au>MURRI, LUIGI</au><au>MURATORIO, ALBERTO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dream Structure in Parkinsonʼs Patients</atitle><jtitle>The journal of nervous and mental disease</jtitle><addtitle>J Nerv Ment Dis</addtitle><date>1992-08</date><risdate>1992</risdate><volume>180</volume><issue>8</issue><spage>516</spage><epage>523</epage><pages>516-523</pages><issn>0022-3018</issn><eissn>1539-736X</eissn><coden>JNMDAN</coden><abstract>Dream reports of patients with Parkinsonʼs disease (PD) were analyzed to ascertain whether cognitive deficits associated with this nonfocal brain pathology influence dream structure or dream recall. Fifteen outpatients with idiopathic PD were sampled (diagnosed from 1 to 10 years and currently in stage II or III of Hoehn and Yarhʼs scale); all were without psychiatric symptoms or major medical illnesses and were currently being treated with L-dopa. After an adaptation night in the sleep laboratory, each patient spent a night in which he/she was awakened at least twice in rapid eye movement sleep and asked to report dream experience. Thirteen patients were able to report at least one dream. Overall frequency of dream recall (71.4%) was fully compatible with normative data for the elderly. Multiple regression analyses showed that both the length of the dream report as story and the organization of contents into coherent episodes (analyzed using Mandler and Johnsonʼs story grammar) varied significantly in relation to level of cognitive functioning and, in part, of language comprehension, but not in relation to age, illness duration, and dose of L-dopa.</abstract><cop>Hagerstown, MD</cop><pub>Williams &amp; Wilkins</pub><pmid>1500934</pmid><doi>10.1097/00005053-199208000-00007</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3018
ispartof The journal of nervous and mental disease, 1992-08, Vol.180 (8), p.516-523
issn 0022-3018
1539-736X
language eng
recordid cdi_proquest_miscellaneous_73133363
source MEDLINE; Journals@Ovid Complete
subjects Age Factors
Aged
Ambulatory Care
Biological and medical sciences
Cognition Disorders - diagnosis
Cognition Disorders - psychology
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dose-Response Relationship, Drug
Dreams - drug effects
Dreams - psychology
Female
Humans
Language Tests
Levodopa - pharmacology
Levodopa - therapeutic use
Male
Medical sciences
Mental Recall - drug effects
Middle Aged
Neurology
Neuropsychological Tests
Parkinson Disease - diagnosis
Parkinson Disease - drug therapy
Parkinson Disease - psychology
Time Factors
title Dream Structure in Parkinsonʼs Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A49%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dream%20Structure%20in%20Parkinson%CA%BCs%20Patients&rft.jtitle=The%20journal%20of%20nervous%20and%20mental%20disease&rft.au=CIPOLLI,%20CARLO&rft.date=1992-08&rft.volume=180&rft.issue=8&rft.spage=516&rft.epage=523&rft.pages=516-523&rft.issn=0022-3018&rft.eissn=1539-736X&rft.coden=JNMDAN&rft_id=info:doi/10.1097/00005053-199208000-00007&rft_dat=%3Cproquest_cross%3E73133363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73133363&rft_id=info:pmid/1500934&rfr_iscdi=true